# EDGAR Filing Document

**Accession Number:** 0002119429
**File Stem:** 0002119429-26-000002
**Filing Date:** 2026-3
**Character Count:** 5736
**Document Hash:** 5e1486cb6e5cbff1828739792f6ea364
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002119429-26-000002.hdr.sgml**: 20260316

**ACCESSION NUMBER**: 0002119429-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260306

**FILED AS OF DATE**: 20260316

**DATE AS OF CHANGE**: 20260316

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Sewell Brandon Elliot
- **CENTRAL INDEX KEY:** 0002119429

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-06544
- **FILM NUMBER:** 26757689

**MAIL ADDRESS:**
- **STREET 1:** 1390 ENCLAVE PARKWAY
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77077
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SYSCO CORP
- **CENTRAL INDEX KEY:** 0000096021
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-GROCERIES & RELATED PRODUCTS [5140]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 741648137
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0627

**BUSINESS ADDRESS:**
- **STREET 1:** 1390 ENCLAVE PKWY
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77077
- **BUSINESS PHONE:** 281-584-1390

**MAIL ADDRESS:**
- **STREET 1:** 1390 ENCLAVE PKWY
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77077

## Ex-24

![](executedsewellsection16p001.jpg)

------

![](executedsewellsection16p002.jpg)

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Sewell Brandon Elliot<br><sub>(Last) (First) (Middle)</sub><br>1390 ENCLAVE PARKWAY<br><sub>(Street)</sub><br>HOUSTON, TX 77077<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SYSCO CORP [ SYY ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-06 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Interim CFO_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 4277.652 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to buy) | <sup>(1)</sup> | 2031-08-18 | Common Stock | 2492 | $76.94 | D |  |
| Stock Options (Right to buy) | <sup>(2)</sup> | 2032-08-17 | Common Stock | 2844 | $85.57 | D |  |
| Stock Options (Right to buy) | <sup>(3)</sup> | 2033-08-09 | Common Stock | 2507 | $73.53 | D |  |
| Stock Options (Right to buy) | <sup>(4)</sup> | 2034-08-20 | Common Stock | 2583 | $76.54 | D |  |
| Stock Options (Right to buy) | <sup>(5)</sup> | 2035-08-20 | Common Stock | 5086 | $80.98 | D |  |

---

### Footnotes:

(1) One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively.  No options may be exercised prior to 08/20/2021. Options will expire on 08/18/2031.

(2) One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively.  No options may be exercised prior to 08/18/2023. Options will expire on 08/17/2032.

(3) One-third of the shares covered by the grant vest and are exercisable on 8/10/2024,  8/10/2025 and 8/10/2026, respectively.  No options may be exercised prior to 8/10/2024. Options will expire on 8/9/2033.

(4) One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. No options may be exercised prior to 8/21/2025. Options will expire on 8/20/2034.

(5) Stock options granted on 08/21/2025 and become exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

**Signature:** /s/Andrew Wurdack, Attorney-in-Fact  
**Date:** 2026-03-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**